<DOC>
	<DOCNO>NCT02652351</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy human umbilical cord mesenchymal stem cell ( hUC-MSC ) Hepatic Cirrhosis .</brief_summary>
	<brief_title>Human Umbilical Cord-Mesenchymal Stem Cells Hepatic Cirrhosis</brief_title>
	<detailed_description>Human umbilical cord mesenchymal stem cell exhibit potential differentiate mature cell typical several tissue , confirm vivo vitro experiment . There clinical report describe umbilical cord mesenchymal stem cell treatment Hepatic Cirrhosis . To investigate effect hUC-MSC treatment Hepatic Cirrhosis , 20 patient Hepatic Cirrhosis enrol receive 4 time hUC-MSC transplantation .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>The patient sign informed consent document ; Clinical , radiological , biochemical evidence liver cirrhosis . Pregnant woman lactate mother ; Patients receive antiinflammatory drug include herbdrug within 14 day ; Patients receive drug intraarticular injection treatment within 2 month prior enrollment ; Patients positive human immunodeficiency ( HIV ) screen indicative current pas infection ; Abnormal blood coagulation , combine tumor special condition ; Patients participate clinical trial within three month prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Stem cell</keyword>
	<keyword>Human Umbilical Cord Mesenchymal Stem Cell</keyword>
	<keyword>Mesenchymal Stem Cell</keyword>
	<keyword>Hepatic Cirrhosis</keyword>
</DOC>